Literature DB >> 4138088

Long-term assessment of cyclophosphamide therapy for nephrosis in children.

J McDonald, A V Murphy, G C Arneil.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4138088     DOI: 10.1016/s0140-6736(74)92073-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.

Authors:  B Oemar; J Brodehl
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

2.  Minimal change nephrotic syndrome and cyclophosphamide.

Authors:  R S Trompeter
Journal:  Arch Dis Child       Date:  1986-08       Impact factor: 3.791

3.  Management and diagnosis of children with the nephrotic syndrome.

Authors: 
Journal:  Br Med J       Date:  1977-10-29

Review 4.  Problems with immunosuppressive agents in renal disease.

Authors:  J S Cameron
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

Review 5.  Immunosuppressive therapy in the nephrotic syndrome in children.

Authors:  R S Trompeter
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

Review 6.  Response of paraneoplastic syndromes to antineoplastic therapy.

Authors:  M Markman
Journal:  West J Med       Date:  1986-05

7.  Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie.

Authors: 
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

8.  Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology.

Authors:  P Niaudet
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

9.  Clinical use of immunosuppressive drugs: part II.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

10.  Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook.

Authors:  Udo Vester; Birgitta Kranz; Stephanie Zimmermann; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2003-05-16       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.